Find A Physician

Return to Dr. Joel Lavine Appointed Chief of Pediatric Gastroenterology, Morgan Stanley Children's Hospital Overview

More on Dr. Joel Lavine Appointed Chief of Pediatric Gastroenterology, Morgan Stanley Children's Hospital

Newsroom

Return to Dr. Joel Lavine Appointed Chief of Pediatric Gastroenterology, Morgan Stanley Children's Hospital Overview

More on Dr. Joel Lavine Appointed Chief of Pediatric Gastroenterology, Morgan Stanley Children's Hospital


Research and Clinical Trials

Return to Dr. Joel Lavine Appointed Chief of Pediatric Gastroenterology, Morgan Stanley Children's Hospital Overview

More on Dr. Joel Lavine Appointed Chief of Pediatric Gastroenterology, Morgan Stanley Children's Hospital

Dr. Joel Lavine Appointed Chief of Pediatric Gastroenterology, Morgan Stanley Children's Hospital

New York (Oct 28, 2010)

Dr. Joel Levin

NewYork-Presbyterian Morgan Stanley Children's Hospital and Columbia University Medical Center has appointed Joel E. Lavine, MD, as Chief of Pediatric Gastroenterology, Hepatology and Nutrition. A noted physician-scientist, Dr. Lavine, who is also Professor of Pediatrics at Columbia, has devoted his career to helping children with acute and chronic liver diseases.

Morgan Stanley Children's Hospital welcomes Dr. Lavine from the University of California, San Diego, where he was Professor and Vice Chairman of Pediatrics, and Chief of the Division of Gastroenterology, Hepatology and Nutrition at Rady Children's Hospital for 15 years. He also served as Medical Director of the Liver Transplant Program. While at the University of California, Dr. Lavine oversaw faculty development and the pediatric fellowship programs at the University of California, and was Fellowship Director for Pediatric Gastroenterology, Hepatology and Nutrition. Prior to joining the University of California, San Diego, Dr. Lavine was a faculty member at Harvard Medical School and Director of Liver Research at The Children's Hospital, Boston from 1991 to 1995.

Dr. Lavine earned his doctorate in molecular biology in 1980 at the University of California, Santa Barbara, and his medical degree from University of California, San Diego, in 1984. He completed a residency in pediatrics at the University of California, San Francisco, in 1986, followed by a fellowship in

pediatric gastroenterology through 1989.

Outstanding Researcher in Pediatric Liver Disease

For the past 15 years, Dr. Lavine's research interests have focused on fatty liver disease and viral hepatitis in children. He is a National Institutes of Health-funded principal investigator for studies related to treatment, natural history, etiopathogenesis and genetics of fatty liver disease. While at the University of California, he received several grants from the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) and NICHD for a national seven-year study on fatty liver disease in children and adults. This study was renewed for an additional $4.2 million for five more years. Dr. Lavine serves on the Executive Committee and Chairs the Steering and Pediatric Committees for the national multi-center network. He also serves as Chair of the NIDDK Data and Safety Monitoring Board for the Cholestatic Liver Disease Research and Education Network, chairs multiple grant review committees for the NIDDK, and serves as Chair of the NIDDK External Advisory Board on adolescent bariatric surgery.

The Division of Gastroenterology, Hepatology and Nutrition

The Division of Gastroenterology, Hepatology and Nutrition at Morgan Stanley Children’s Hospital has long been at the forefront of care and research for children with gastrointestinal diseases and is a major clinical and research center. With 12 faculty members, two nurse practitioners and four full-time dietitians, the program is recognized for the treatment of digestive and liver disorders, including end-stage liver disease, inflammatory bowel disease, celiac disease, short bowel syndrome, pancreatic disorders, obesity and fatty liver disease. The Division also has the only liver and small bowel transplantation center in the Tri-State area, and has physicians highly skilled in the performance of advanced endoscopy, liver biopsy and capsule endoscopy. They also have extensive experience with the endoscopic management of gastrointestinal bleeding, and perform endoscopic ultrasound and retrograde cholangiopancreatography. The Division is closely linked to the renowned Institute for Human Nutrition, and also has a large liver and intestinal failure program in collaboration with the transplant program, the only one of its kind in New York that performs both liver and small bowel transplantation.

Under Dr. Lavine's leadership, the Division is furthering the integration of its clinical, research, and educational activities, with plans to develop or expand programs in pediatric functional bowel disorders, inflammatory bowel disease, allergies of the GI tract, celiac disease, and health outcomes improvement. Most recently, the Division launched a new Fatty Liver Clinic for the study and management of children with Nonalcoholic Fatty Liver Disease. According to studies cited by Dr. Lavine, this disease is under-recognized by healthcare providers. The site is a member of the NASH Clinical Research Network funded by the NIH with the goal of better understanding and treatment.  Patients seen in the clinic will have the opportunity to enroll in observational and treatment studies.

Dr. Lavine continues research in fatty liver disease, studying genetic predispositions, etiopathogenesis, and non-invasive methods of diagnosing the disease other than liver biopsy. He is also exploring fibrosis quantitation; developing methods of assessing inflammation or cellular injury; and exploring serum markers to determine more benign or aggressive forms of the disease.

For more information on the services and programs of the Division of Gastroenterology, Hepatology and Nutrition at Morgan Stanley Children's Hospital, please contact Dr. Lavine at (212) 304-5533.

  • Bookmark
  • Print

    Find a Doctor

Click the button above or call
1 877 NYP WELL


eNewsletters


Newsroom



Top of page